Cargando…
Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194436/ https://www.ncbi.nlm.nih.gov/pubmed/33942766 http://dx.doi.org/10.4103/lungindia.lungindia_93_20 |
| _version_ | 1783706416940318720 |
|---|---|
| author | Choudhury, Shouvik Bala, Moumita Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep |
| author_facet | Choudhury, Shouvik Bala, Moumita Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep |
| author_sort | Choudhury, Shouvik |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8194436 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81944362021-06-25 Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia Choudhury, Shouvik Bala, Moumita Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep Lung India Research Letters Wolters Kluwer - Medknow 2021 2021-04-30 /pmc/articles/PMC8194436/ /pubmed/33942766 http://dx.doi.org/10.4103/lungindia.lungindia_93_20 Text en Copyright: © 2021 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Research Letters Choudhury, Shouvik Bala, Moumita Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia |
| title | Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia |
| title_full | Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia |
| title_fullStr | Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia |
| title_full_unstemmed | Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia |
| title_short | Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia |
| title_sort | lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194436/ https://www.ncbi.nlm.nih.gov/pubmed/33942766 http://dx.doi.org/10.4103/lungindia.lungindia_93_20 |
| work_keys_str_mv | AT choudhuryshouvik lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia AT balamoumita lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia AT chakrabortydwaipayansarathi lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia AT lahirysandeep lefamulinarecentlyapprovednovelantibacterialagenttofightagainstcommunityacquiredbacterialpneumonia |